Robert Corno

Robert Corno serves as a secondary procurement liaison within the National Institute of Allergy and Infectious Diseases (NIAID), supporting the agency’s mission to accelerate biomedical research for infectious, immunologic, and allergic disease threats. While not the primary contracting officer, he plays a critical role in facilitating the acquisition lifecycle for high-containment research services and laboratory infrastructure projects. His responsibilities include coordinating requirements validation, contract administration support, and vendor engagement for complex R&D initiatives aligned with NIAID’s strategic priorities in biosafety and medical countermeasure development. He typically handles acquisitions under the Research and Development in the Physical, Engineering, and Life Sciences NAICS category, focusing on technical services that enable advanced pathogen research and diagnostic innovation. Corno’s procurement activities are closely aligned with Quality Biological, Inc., a key contractor providing specialized biological reagents and high-containment laboratory materials, as well as Genomic Labs Ltd., which supports advanced genomic sequencing and bioinformatics infrastructure. These partnerships reflect a pattern of sustained, mission-critical vendor relationships centered on proprietary biological products and specialized research support services. His working relationships are characterized by long-term engagement with niche suppliers possessing unique biosafety certifications and technical expertise in handling select agents and high-risk pathogens. Corno’s acquisition portfolio exhibits no set-aside preferences, with 100% of procurements conducted under full and open competition. This reflects NIAID’s operational need for specialized capabilities that are currently available only through a limited pool of highly qualified vendors with advanced biosafety credentials. While small business participation is not formally prioritized, this stems from technical constraints rather than policy avoidance, as the required expertise often resides in firms with extensive regulatory and containment infrastructure. His primary focus is on NAICS 541715, encompassing research and development services in life sciences, particularly those involving pathogen characterization, diagnostic assay development, and biosafety level 3/4 laboratory support. He procures technical services requiring specialized containment, validated reagent supply chains, and compliance with federal biosafety regulations, demonstrating deep domain expertise in public health preparedness and high-consequence pathogen research.